Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015

Plasmid-mediated colistin resistance (mcr-1gene): three months later, the story unfolds

(2016) Robert L. Skov et al.   Eurosurveillance

Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli

(2016) Laurent Poirel et al.   LANCET INFECTIOUS DISEASES

Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1

(2016) Xu Yao et al.   LANCET INFECTIOUS DISEASES

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

(2016) Yi-Yun Liu et al.   LANCET INFECTIOUS DISEASES

OXA-48 ProducingKlebsiella pneumoniaein a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition?

(2016) Erlangga Yusuf et al.   Microbial Drug Resistance

Emergence of OXA-162 Carbapenemase- and DHA-1 AmpC Cephalosporinase-Producing Sequence Type 11 Klebsiella pneumoniae Causing Community-Onset Infection in Greece

(2015) Evangelia Voulgari et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem

(2015) Jesús Oteo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014

(2015) Saverio Giuseppe Parisi et al.   BMC INFECTIOUS DISEASES

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

(2015) Etienne Ruppé et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the BYG Carba Test, a New Electrochemical Assay for Rapid Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae

(2015) Pierre Bogaerts et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Infection due to travel-related carbapenemase-producingEnterobacteriaceae, a largely underestimated phenomenon in Belgium

(2015) B. Jans et al.   ACTA CLINICA BELGICA

Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland

(2015) Katrin Zurfluh et al.   Antimicrobial Resistance and Infection Control

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013

(2013) C Glasner et al.   Eurosurveillance

Validation of carbapenemase and extended-spectrum  -lactamase multiplex endpoint PCR assays according to ISO 15189

(2013) P. Bogaerts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium

(2013) Te-Din Huang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

(2012) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenemase-producing Enterobacteriaceae: a call for action!

(2012) P. Nordmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

(2012) E. Miró et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Controlled Performance Evaluation of the DiversiLab Repetitive-Sequence-Based Genotyping System for Typing Multidrug-Resistant Health Care-Associated Bacterial Pathogens

(2011) A. Deplano et al.   JOURNAL OF CLINICAL MICROBIOLOGY